PIN Pharma, Inc. Email Format

Biotechnology ResearchNew York, United States2-10 Employees

PIN Pharma is a venture-backed company that focuses on researching and developing immune modulators for a broad range of indications, including oncology, autoimmunity, and neurodegeneration. Its unique technology enables PIN Pharma to develop first-in-class, next generation compounds that target the innate immune system to drive adaptive immune responses. PIN Pharma is developing its lead compound, PIN-2, for initial indications in oncology. In preclinical models, PIN-2 has demonstrated synergy with several cytotoxic therapies as well as checkpoint inhibitors. In the clinic, PIN Pharma has finished its first-in-human study conducted in all comers with solid tumors for the purpose of providing proof-of-concept through the measuring of key immune markers.

Sign up for free to view info

Company overview Employee directory